未登录

C

Chao Lin

fudan university

H指数:23

被引数:1,997

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TREM1 Blockade Reprograms Tumor-Associated Macrophages and Improves Anti-PD-1 Efficacy in Gastric Cancer

TREM1 阻断重编程肿瘤相关巨噬细胞并提高胃癌中抗 PD-1 疗效

Journal of Gastroenterology and Hepatology

IF3.4

2026-09-070

PRE

Smad4 loss identifies aggressive subtype with immunotherapy and anti-HER-2 treatment resistance in gastric cancer

Smad4缺失可识别对免疫治疗和抗HER-2治疗耐药的胃癌侵袭性亚型

BRITISH JOURNAL OF CANCER

IF6.8

2025-04-250

PRE

Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer

BRITISH JOURNAL OF CANCER

IF6.8

2024-08-313

OA

Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2023-11-075

OAAI

Is Pathologic Complete Response a Good Predictor for the Long-Term, Clinical Outcome in Patients with Gastric Cancer After Neoadjuvant Chemotherapy? A Retrospective, Multi-institution Study in China (Jun, 10.1245/s10434-023-13728-5, 2023)

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2023-07-090

OA

C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer

BRITISH JOURNAL OF CANCER

IF6.8

2023-07-089

OA

ASO Author Reflections: The Prognostic Value of Pathologic Complete Response After Neoadjuvant Chemotherapy in Gastric Cancer

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2023-06-250

OA

Is Pathologic Complete Response a Good Predictor for the Long-Term, Clinical Outcome in Patients with Gastric Cancer After Neoadjuvant Chemotherapy? A Retrospective, Multi-institution Study in China

病理完全缓解是新辅助化疗后胃癌患者长期临床结局的良好预测指标吗？中国多机构回顾性研究

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2023-06-195

PRE

Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2023-02-2512

OAAI

Intratumoral PD-1+CD8+ T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer

BRITISH JOURNAL OF CANCER

IF6.8

2022-08-2417

OA

Impact of intratumoural CD73 expression on prognosis and therapeutic response in patients with gastric cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2021-11-0117

PREAI

TIM3+ cells in gastric cancer: clinical correlates and association with immune context

BRITISH JOURNAL OF CANCER

IF6.8

2021-11-0116

OA

Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer

IF6.3

2021-09-1519

OA

Intratumoral CXCR5+CD8+T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer

NATURE COMMUNICATIONS

IF15.7

2021-05-2552

OAAI

Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+T cells enriched gastric cancer patients

富含CXCL13 CD8 T细胞的胃癌患者的不良临床结局和免疫逃避环境

IF6.3

2021-04-2724

OAAI

ASO Author Reflections: Optimization of Tumor Therapy for the Specific Immune Microenvironment of Gastric Cancer

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2021-03-290

PRE

Clinical Outcomes and Immune Metrics in Intratumoral Basophil-Enriched Gastric Cancer Patients

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2021-03-1821

PRE

Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response

IF6.3

2020-12-1510

OA

Intratumoral CD103+CD4+ T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients

IF6.3

2020-11-2211

OAAI

Tumor-infiltrating podoplanin+ cells in gastric cancer: clinical outcomes and association with immune contexture

胃癌中的肿瘤浸润性podotlanin细胞: 临床结果及其与免疫环境的关联

IF6.3

2020-11-138

OAAI